Clinical Trials Directory

Trials / Terminated

TerminatedNCT02093494

Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device When Collected Through Peripheral Intravenous Catheters

A Randomized, Open Label Study to Evaluate the Effectiveness of the MMT Initial Specimen Diversion Device in Reducing Blood Culture Contamination Compared to Laboratory Standard Procedures When Collected Through Peripheral Intravenous Catheters (PIVC)

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Magnolia Medical Technologies, Inc. · Industry
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

This is a randomized, open label study to evaluate the Initial Specimen Diversion Device (ISDD) in reducing the contamination rate in blood culture analysis. Blood culture data will be derived from inpatient and/or outpatient settings in a variety of hospital departments (e.g. ER, surgical, medical, etc.). Only samples that are collected via PIVC's may be included in this study. The ISDD will be compared to current laboratory practices for the collection of blood for culture purposes. Laboratory Standard Procedures (LSP) is defined as collection of venipuncture blood for culture without an initial diversion method to divert and sequester potential blood contaminants.

Conditions

Interventions

TypeNameDescription
DEVICEInitial Specimen Diversion Device (ISDD)
PROCEDURELab standard practice (LSP)
DEVICEPeripheral Intravenous Catheters (PIVC)

Timeline

Start date
2014-01-01
Primary completion
2015-05-01
Completion
2015-05-01
First posted
2014-03-21
Last updated
2017-08-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02093494. Inclusion in this directory is not an endorsement.